Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36


Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.

Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM.

Drugs. 2016 Mar;76(4):459-83. doi: 10.1007/s40265-015-0534-3. Review.


Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism.

Witt DM, Clark NP, Kaatz S, Schnurr T, Ansell JE.

J Thromb Thrombolysis. 2016 Jan;41(1):187-205. doi: 10.1007/s11239-015-1319-y.


The antiphospholipid syndrome: still an enigma.

Chaturvedi S, McCrae KR.

Hematology Am Soc Hematol Educ Program. 2015;2015:53-60. doi: 10.1182/asheducation-2015.1.53.


Sarcoidosis and Antiphospholipid Syndrome: A Systematic Review of Cases.

Pathak R, Khanal R, Aryal MR, Giri S, Karmacharya P, Pathak B, Acharya U, Bhatt VR.

N Am J Med Sci. 2015 Sep;7(9):379-83. doi: 10.4103/1947-2714.166213. Review.


Therapeutic challenges after successful thrombectomy in a patient with an antiphospholipid syndrome associated M1-occlusion: A case report.

Stadler K, Mutzenbach JS, Kalss G, Sellner J, Al-Schameri AR, Trinka E, Killer-Oberpfalzer M.

Interv Neuroradiol. 2015 Oct;21(5):598-602. doi: 10.1177/1591019915590371. Epub 2015 Jul 1.


Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

Chighizola CB, Ubiali T, Meroni PL.

J Immunol Res. 2015;2015:951424. doi: 10.1155/2015/951424. Epub 2015 May 5. Review.


Treatment of the antiphospholipid syndrome.

Galli M.

Auto Immun Highlights. 2013 Dec 22;5(1):1-7. doi: 10.1007/s13317-013-0056-5. eCollection 2014 Jun. Review.


Management of the antiphospholipid syndrome.

Espinosa G, Cervera R.

Auto Immun Highlights. 2010 Jul 10;1(1):15-22. doi: 10.1007/s13317-010-0004-6. eCollection 2010 May. Review.


Multiple thromboses in a patient with systemic lupus erythematosus after splenectomy.

Yang DH.

Case Reports Immunol. 2012;2012:813629. doi: 10.1155/2012/813629. Epub 2012 May 28.


Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.

Cohen H, Doré CJ, Clawson S, Hunt BJ, Isenberg D, Khamashta M, Muirhead N; RAPS Trial Protocol Collaborators.

Lupus. 2015 Sep;24(10):1087-94. doi: 10.1177/0961203315581207. Epub 2015 May 4.


Implant surgery and oral anticoagulant therapy: case report.

Miranda M, Bollero P, D'Ovidio N, Marsango V, Barlattani A Jr.

Oral Implantol (Rome). 2014 Dec 27;7(2):51-6. eCollection 2014 Apr-Jun.


A case of antiphospholipid syndrome refractory to secondary anticoagulating prophylaxis after deep vein thrombosis-pulmonary embolism.

Gu KM, Shin JW, Park IW.

Tuberc Respir Dis (Seoul). 2014 Dec;77(6):274-8. doi: 10.4046/trd.2014.77.6.274. Epub 2014 Dec 31.


Chapter 12: Lupus nephritis.

[No authors listed]

Kidney Int Suppl (2011). 2012 Jun;2(2):221-232. No abstract available.


Diagnosis and treatment of deep-vein thrombosis and approach to venous thromboembolism in obstetrics and gynecology.

Burgazlı KM, Bilgin M, Kavukçu E, Altay MM, Ozkan HT, Coşkun U, Akdere H, Ertan AK.

J Turk Ger Gynecol Assoc. 2011 Sep 1;12(3):168-75. doi: 10.5152/jtgga.2011.39. eCollection 2011. Review.


Latest advances in connective tissue disorders.

Rao V, Bowman S.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):234-49. doi: 10.1177/1759720X13480280.


Arteriopathy, D-dimer, and risk of poor neurologic outcome in childhood-onset arterial ischemic stroke.

Goldenberg NA, Jenkins S, Jack J, Armstrong-Wells J, Fenton LZ, Stence NV, Oleszek J, Boada R, Wilkening GN, Wilkinson C, Soep JB, Miyamoto SD, Bajaj L, Mourani PM, Manco-Johnson MJ, Bernard TJ.

J Pediatr. 2013 May;162(5):1041-6.e1. doi: 10.1016/j.jpeds.2012.11.035. Epub 2012 Dec 20.


Thrombosis in systemic lupus erythematosus: a review article.

Al-Homood IA.

ISRN Rheumatol. 2012;2012:428269. doi: 10.5402/2012/428269. Epub 2012 Jul 30.


Management of antiphospholipid syndrome.

Del Papa N, Vaso N.

Ther Adv Musculoskelet Dis. 2010 Aug;2(4):221-7. doi: 10.1177/1759720X10365969.


Antiphospholipid syndrome and recurrent thrombosis--limitations of current treatment strategies.

Henriques CC, Lourenço F, Lopéz B, Panarra A, Riso N.

BMJ Case Rep. 2012 Mar 8;2012. pii: bcr1120115147. doi: 10.1136/bcr.11.2011.5147.


Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

Items per page

Supplemental Content

Write to the Help Desk